Jing Hao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jing Hao has a total of 136 co-authors. Here are the top co-authors by number of shared publications:
Ruihong Zhang
Key Laboratory of The Ministry of Education for Experimental Teratology, Department of Histology and Embryology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, 44 Wenhua Xi Road, Jinan, Shandong, PR China
17 shared publicationsXiaoli Zhang
Key Laboratory of The Ministry of Education for Experimental Teratology, Department of Histology and Embryology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, People’s Republic of China
17 shared publications- Xiaoli Zhang
Department of Anatomy & Histoembryology, School of Basic Medical Sciences, Shandong University, 250012 Jinan, Shandong, China
9 shared publications Weiwei Cui
8 shared publications- Jie Chai
Department of Gastrointestinal Surgery, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China
7 shared publications - Sujuan Zhi
Key Laboratory of the Ministry of Education for Experimental Teratology, Department of Histology and Embryology, School of Basic Medical Sciences, Cheeloo College of Medicine Shandong University Jinan Shandong People's Republic of China
7 shared publications
Latest Publications
- 19 May 2026
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 367, 152601
Linc00347 suppresses ferroptosis in drug-resistant gastric cancer cells through stabilizing FoxO6 mRNA mediated by YBX1
- 19 May 2026
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 367, 152601
Linc00347 suppresses ferroptosis in drug-resistant gastric cancer cells through stabilizing FoxO6 mRNA mediated by YBX1
- 4 December 2025
- Published by Springer Nature in Gastric Cancer
- Vol. 29 (1) , 97-112
MZF1-AS1/NSUN2 promotes the peritoneal metastasis of gastric cancer by enhancing the stability of RAB13 mRNA
Peritoneal metastasis (PM) is a major contributor to poor prognosis in advanced gastric cancer (GC), yet its molecular mechanisms remain insufficiently understood. The results of bioinformatic analysis and clinical sample validation reveal that LncRNA MZF1-AS1 is significantly upregulated in GC tissues, particularly in peritoneal metastases, and is associated with worse overall and post-progression survival. MZF1-AS1 enhances malignant phenotypes and PM of GC cells in vitro and in vivo. Mechanistically, RAB13 is demonstrated as a functional effector of MZF1-AS1 via RNA-seq. MZF1-AS1 enhances RAB13 expression by promoting its mRNA stability, thereby facilitating GC cell proliferation, EMT, migration, invasion, and stemness. Further, RNA pulldown and Mass Spectrometry reveal that MZF1-AS1 directly binds to NSUN2. MZF1-AS1 strengthens the interaction between NSUN2 and RAB13 mRNA, promoting NSUN2-mediated m5C modification and stabilizing RAB13 mRNA. Our findings uncover a novel epi-transcriptomic mechanism by which MZF1-AS1 promotes GC progression via NSUN2-dependent m5C methylation of RAB13 mRNA, offering new insights into PM pathogenesis and highlighting potential therapeutic targets for advanced GC.
- 4 December 2025
- Published by Springer Nature in Gastric Cancer
- Vol. 29 (1) , 97-112
MZF1-AS1/NSUN2 promotes the peritoneal metastasis of gastric cancer by enhancing the stability of RAB13 mRNA
Peritoneal metastasis (PM) is a major contributor to poor prognosis in advanced gastric cancer (GC), yet its molecular mechanisms remain insufficiently understood. The results of bioinformatic analysis and clinical sample validation reveal that LncRNA MZF1-AS1 is significantly upregulated in GC tissues, particularly in peritoneal metastases, and is associated with worse overall and post-progression survival. MZF1-AS1 enhances malignant phenotypes and PM of GC cells in vitro and in vivo. Mechanistically, RAB13 is demonstrated as a functional effector of MZF1-AS1 via RNA-seq. MZF1-AS1 enhances RAB13 expression by promoting its mRNA stability, thereby facilitating GC cell proliferation, EMT, migration, invasion, and stemness. Further, RNA pulldown and Mass Spectrometry reveal that MZF1-AS1 directly binds to NSUN2. MZF1-AS1 strengthens the interaction between NSUN2 and RAB13 mRNA, promoting NSUN2-mediated m5C modification and stabilizing RAB13 mRNA. Our findings uncover a novel epi-transcriptomic mechanism by which MZF1-AS1 promotes GC progression via NSUN2-dependent m5C methylation of RAB13 mRNA, offering new insights into PM pathogenesis and highlighting potential therapeutic targets for advanced GC.
- Open Access
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Tables 1-3, Figures 1-3 from Sohlh2 Regulates the Stemness and Differentiation of Colon Cancer Stem Cells by Downregulating LncRNA-H19 Transcription
Supplementary Table S1: Primer sequence for qPCR Supplementary Table S2: LncRNAs regulated by Sohlh2 in colon cancer cells Supplementary Table S3: The correlation of Sohlh2 expression and clinical characteristics Supplementary Figure 1: The protein levels of Lgr5, CD133 were downregulated in Sohlh2-overexpressing CSC-derived xenografts, and the levels of TFF2 were upregulated. Supplementary Figure S2: Sohlh2 downregulated the expression of β-catenin in xenograft tumors. Supplementary Figure S3: Sohlh2 upregulated the expression of APC in HCT116 CSCs.
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Tables 1-3, Figures 1-3 from Sohlh2 Regulates the Stemness and Differentiation of Colon Cancer Stem Cells by Downregulating LncRNA-H19 Transcription
Supplementary Table S1: Primer sequence for qPCR Supplementary Table S2: LncRNAs regulated by Sohlh2 in colon cancer cells Supplementary Table S3: The correlation of Sohlh2 expression and clinical characteristics Supplementary Figure 1: The protein levels of Lgr5, CD133 were downregulated in Sohlh2-overexpressing CSC-derived xenografts, and the levels of TFF2 were upregulated. Supplementary Figure S2: Sohlh2 downregulated the expression of β-catenin in xenograft tumors. Supplementary Figure S3: Sohlh2 upregulated the expression of APC in HCT116 CSCs.
- Open Access
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Data from Sohlh2 Regulates the Stemness and Differentiation of Colon Cancer Stem Cells by Downregulating LncRNA-H19 Transcription
Colon cancer stem cells (CSC) are tumor-initiating cells that drive tumorigenesis and progression through self-renewal and various differentiation potency. Therefore, the identification of factors critical for colon CSC function is vital for the development of therapies. Sohlh2 belongs to the superfamily of bhlh transcription factors and serves as a tumor suppressor in several tumors. The role of Sohlh2 in CSCs remains unknown. Here we demonstrated that Sohlh2 was related to the inhibition of LncRNA-H19/miR-141/β-catenin signaling and led to the consequent suppression of colon CSC stemness and the promotion of colon CSC differentiation in vitro and in vivo. Moreover, Sohlh2 could directly bind to the promoter of LncRNA-H19 and repress its transcription activity. LncRNA-H19 mediated the effects of Sohlh2 on colon CSC stemness and differentiation. Clinically, we observed a significant inverse correlation between Sohlh2 and LncRNA-H19, β-catenin, Lgr5, CD133 expression levels, and positive correlation between Sohlh2 and MUC2, TFF2 expression in colon cancer tissues. Collectively, our findings suggest an important role of the Sohlh2/LncRNA-H19/miR-141/β-catenin pathway in regulating colon CSC stemness and differentiation, suggesting potential therapeutic targets for colon cancer.Implications:This study identifies that Sohlh2 directly manipulates LncRNA-H19 transcription and suppresses the β-catenin signaling pathway and the Sohlh2/LncRNA-H19/miR-141/β-catenin signaling pathway plays an essential role in the stemness of colon CSCs.
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessData from Sohlh2 Regulates the Stemness and Differentiation of Colon Cancer Stem Cells by Downregulating LncRNA-H19 Transcription
Colon cancer stem cells (CSC) are tumor-initiating cells that drive tumorigenesis and progression through self-renewal and various differentiation potency. Therefore, the identification of factors critical for colon CSC function is vital for the development of therapies. Sohlh2 belongs to the superfamily of bhlh transcription factors and serves as a tumor suppressor in several tumors. The role of Sohlh2 in CSCs remains unknown. Here we demonstrated that Sohlh2 was related to the inhibition of LncRNA-H19/miR-141/β-catenin signaling and led to the consequent suppression of colon CSC stemness and the promotion of colon CSC differentiation in vitro and in vivo. Moreover, Sohlh2 could directly bind to the promoter of LncRNA-H19 and repress its transcription activity. LncRNA-H19 mediated the effects of Sohlh2 on colon CSC stemness and differentiation. Clinically, we observed a significant inverse correlation between Sohlh2 and LncRNA-H19, β-catenin, Lgr5, CD133 expression levels, and positive correlation between Sohlh2 and MUC2, TFF2 expression in colon cancer tissues. Collectively, our findings suggest an important role of the Sohlh2/LncRNA-H19/miR-141/β-catenin pathway in regulating colon CSC stemness and differentiation, suggesting potential therapeutic targets for colon cancer.Implications:This study identifies that Sohlh2 directly manipulates LncRNA-H19 transcription and suppresses the β-catenin signaling pathway and the Sohlh2/LncRNA-H19/miR-141/β-catenin signaling pathway plays an essential role in the stemness of colon CSCs.
- Open Access
- 26 May 2025
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 29 (10) , e70599
Sohlh1 Modulates the Stemness and Differentiation of Glioma Stem‐Like Cells by Inactivation of Wnt/β‐Catenin Signalling Pathway via SFRP1
Glioma stem‐like cells (GSLCs) are tumour initiating cells that drive tumorigenesis and progression through self‐renewal and various differentiation potencies. Therefore, the identification of genes required for GSLC stemness and differentiation is vital for the development of novel targeted therapies. Sohlh1 belongs to the superfamily of bhlh transcription factors and serves as a tumour suppressor in glioma. The role of Sohlh1 in GSLCs remains unknown. Here, we demonstrated that Sohlh1 functioned through the SFRP1/Wnt/β‐catenin signalling pathway and led to the consequent suppression of GSLC stemness and the promotion of GSLC differentiation in vitro and in vivo. Moreover, Sohlh1 could directly bind to the promoter of SFRP1 and promote its transcriptional activity. SFRP1 mediated the effects of Sohlh1 on GSLC stemness and differentiation. Clinically, we observed a significant inverse correlation between Sohlh1 and Nestin expression levels, and a positive correlation between Sohlh1 and SFRP1 expression in glioma tissues. Collectively, our findings suggest an important role of the Sohlh1/SFRP1/Wnt/β‐catenin pathway in regulating GSLC stemness and differentiation, suggesting potential therapeutic targets for glioma.
- 26 May 2025
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 29 (10) , e70599
Open AccessSohlh1 Modulates the Stemness and Differentiation of Glioma Stem‐Like Cells by Inactivation of Wnt/β‐Catenin Signalling Pathway via SFRP1
Glioma stem‐like cells (GSLCs) are tumour initiating cells that drive tumorigenesis and progression through self‐renewal and various differentiation potencies. Therefore, the identification of genes required for GSLC stemness and differentiation is vital for the development of novel targeted therapies. Sohlh1 belongs to the superfamily of bhlh transcription factors and serves as a tumour suppressor in glioma. The role of Sohlh1 in GSLCs remains unknown. Here, we demonstrated that Sohlh1 functioned through the SFRP1/Wnt/β‐catenin signalling pathway and led to the consequent suppression of GSLC stemness and the promotion of GSLC differentiation in vitro and in vivo. Moreover, Sohlh1 could directly bind to the promoter of SFRP1 and promote its transcriptional activity. SFRP1 mediated the effects of Sohlh1 on GSLC stemness and differentiation. Clinically, we observed a significant inverse correlation between Sohlh1 and Nestin expression levels, and a positive correlation between Sohlh1 and SFRP1 expression in glioma tissues. Collectively, our findings suggest an important role of the Sohlh1/SFRP1/Wnt/β‐catenin pathway in regulating GSLC stemness and differentiation, suggesting potential therapeutic targets for glioma.
- 22 October 2024
- Published by Wiley in Molecular Carcinogenesis
- Vol. 64 (1) , 138-151
Sohlh2 Promotes the Progression of Hepatocellular Carcinoma via TGM2‐Mediated Autophagy
Liver cancer is the third leading cause of cancer‐related deaths worldwide, with hepatocellular carcinoma (HCC) accounting for 85% of liver cancer‐related deaths. Autophagy controls HCC cell growth, invasion, metastasis, drug resistance, and stemness. Spermatogenesis and oogenesis basic helix‐loop‐helix transcription factor 2 (Sohlh2) can bind to the E‐boxes in the promoter regions of target genes, which are involved in multiple neoplasms. In this study, Sohlh2 was highly expressed in HCC tissues and was related to poor prognosis. Moreover, Sohlh2 overexpression promoted the proliferation, migration, invasion, and metastasis of HCC cells in vivo and in vitro. However, Sohlh2 silencing inhibited proliferation, migration, invasion, and metastasis of HCC cells in vivo and in vitro. Mechanistically, Sohlh2 could bind to the promoter of TGM2 and enhance its transcriptional activity, thereby enhancing the autophagy of HCC cells. Furthermore, Sohlh2 protein levels were positively associated with TGM2 expression in HCC tissues. Taken together, these results demonstrate that Sohlh2 can promote HCC progression via TGM2‐mediated autophagy, implying that Sohlh2 is a promising candidate for HCC treatment.
- 22 October 2024
- Published by Wiley in Molecular Carcinogenesis
- Vol. 64 (1) , 138-151
Sohlh2 Promotes the Progression of Hepatocellular Carcinoma via TGM2‐Mediated Autophagy
Liver cancer is the third leading cause of cancer‐related deaths worldwide, with hepatocellular carcinoma (HCC) accounting for 85% of liver cancer‐related deaths. Autophagy controls HCC cell growth, invasion, metastasis, drug resistance, and stemness. Spermatogenesis and oogenesis basic helix‐loop‐helix transcription factor 2 (Sohlh2) can bind to the E‐boxes in the promoter regions of target genes, which are involved in multiple neoplasms. In this study, Sohlh2 was highly expressed in HCC tissues and was related to poor prognosis. Moreover, Sohlh2 overexpression promoted the proliferation, migration, invasion, and metastasis of HCC cells in vivo and in vitro. However, Sohlh2 silencing inhibited proliferation, migration, invasion, and metastasis of HCC cells in vivo and in vitro. Mechanistically, Sohlh2 could bind to the promoter of TGM2 and enhance its transcriptional activity, thereby enhancing the autophagy of HCC cells. Furthermore, Sohlh2 protein levels were positively associated with TGM2 expression in HCC tissues. Taken together, these results demonstrate that Sohlh2 can promote HCC progression via TGM2‐mediated autophagy, implying that Sohlh2 is a promising candidate for HCC treatment.
- Open Access
- 6 June 2024
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 15, 1394941
Honghua Xiaoyao tablet combined with estradiol improves ovarian function in D-galactose-induced aging mice by reducing apoptosis and affecting the release of reproductive hormones: an in vivo study
Context: It is very necessary to delay ovarian aging and prevent age-related health problems. The active ingredient in Honghua Xiaoyao tablet (HHXYT) has the effects of anti-oxidation, anti-inflammation, immune regulation and so on.Objective: To explore the effect and mechanism of Honghua Xiaoyao tablet on aging model mice.Materials and methods: The aging model was established by intraperitoneal injection of D-galactose in model mice. The mice in the HHXYT-L,M,H group were given 0.3 g/kg, 0.6 g/kg and 1.2 g/kg Honghua Xiaoyao tablet suspension respectively, and the HHXYT-M + E2 group was given 0.6 g/kg HHXYT +0.13 mg/kg estradiol valerate for 30 days. In this study, ELISA, HE, Western blot, IH and TUNEL were used.Results: HHXYT + E2 can improve the gonadal index, estrous cycle of aging mice. In HHXYT-M + E2 group, the level of FSH and LH decreased, while E2 and AMH increased significantly. The number of growing follicles in HHXYT-M + E2 group increased, which was better than that of HHXYT alone. Western blot results showed that HHXYT-M + E2 group decreased the expression of Bax, cleaved-Parp, cleaved-Casp-3 and CytC molecules and increased the expression of Bcl-2 in ovarian tissue. FSHR expression decreased in model group and increased in HHXYT group. TUNEL staining showed that the number of apoptotic cells in HHXYT group was reduced, and the HHXYT-M + E2 group was the most significantly.Discussion and conclusion: HHXYT can improve the level of sex hormones and increase the number of growing follicles in aging mice. HHXYT-M + E2 group has the best effect, and its mechanism may be related to reducing ovarian granulosa cell apoptosis.
- 6 June 2024
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 15, 1394941
Open AccessHonghua Xiaoyao tablet combined with estradiol improves ovarian function in D-galactose-induced aging mice by reducing apoptosis and affecting the release of reproductive hormones: an in vivo study
Context: It is very necessary to delay ovarian aging and prevent age-related health problems. The active ingredient in Honghua Xiaoyao tablet (HHXYT) has the effects of anti-oxidation, anti-inflammation, immune regulation and so on.Objective: To explore the effect and mechanism of Honghua Xiaoyao tablet on aging model mice.Materials and methods: The aging model was established by intraperitoneal injection of D-galactose in model mice. The mice in the HHXYT-L,M,H group were given 0.3 g/kg, 0.6 g/kg and 1.2 g/kg Honghua Xiaoyao tablet suspension respectively, and the HHXYT-M + E2 group was given 0.6 g/kg HHXYT +0.13 mg/kg estradiol valerate for 30 days. In this study, ELISA, HE, Western blot, IH and TUNEL were used.Results: HHXYT + E2 can improve the gonadal index, estrous cycle of aging mice. In HHXYT-M + E2 group, the level of FSH and LH decreased, while E2 and AMH increased significantly. The number of growing follicles in HHXYT-M + E2 group increased, which was better than that of HHXYT alone. Western blot results showed that HHXYT-M + E2 group decreased the expression of Bax, cleaved-Parp, cleaved-Casp-3 and CytC molecules and increased the expression of Bcl-2 in ovarian tissue. FSHR expression decreased in model group and increased in HHXYT group. TUNEL staining showed that the number of apoptotic cells in HHXYT group was reduced, and the HHXYT-M + E2 group was the most significantly.Discussion and conclusion: HHXYT can improve the level of sex hormones and increase the number of growing follicles in aging mice. HHXYT-M + E2 group has the best effect, and its mechanism may be related to reducing ovarian granulosa cell apoptosis.
- Open Access
- 20 December 2023
- Published by Springer Nature in Cell Death & Disease
- Vol. 14 (12) , 1-13
TRIM21-mediated Sohlh2 ubiquitination suppresses M2 macrophage polarization and progression of triple-negative breast cancer
Lung metastasis is the major cause of death in patients with triple-negative breast cancer (TNBC). Tumor-associated macrophages (TAMs) represent the M2-like phenotype with potent immunosuppressive activity, and play a pro-tumor role in TNBC lung metastasis. Sohlh2 belongs to the basic helix-loop-helix transcription factor family. However, its role in macrophages polarization remains unknown, especially in TNBC progression. Here we demonstrated that Sohlh2 overexpression promoted M2 macrophage polarization. Moreover, high expression of Sohlh2 in M2-like macrophage enhanced TNBC cell growth, migration and lung metastasis in vivo and in vitro. Mechanistically, we revealed that Sohlh2 functioned through up-regulating LXRα, ABCA1, ABCG1 expression and disturbing the lipid homeostasis on the membrane of macrophages. Sohlh2 could directly bind to the promoter of LXRα and promote its transcription activity. E3 ubiquitin ligase TRIM21 promoted Sohlh2 ubiquitination and degradation, and suppressed M2 macrophage polarization and TNBC progression. Collectively, our findings suggested that Sohlh2 in macrophage could be a novel therapeutic target for TNBC metastatic treatment.
- 20 December 2023
- Published by Springer Nature in Cell Death & Disease
- Vol. 14 (12) , 1-13
Open AccessTRIM21-mediated Sohlh2 ubiquitination suppresses M2 macrophage polarization and progression of triple-negative breast cancer
Lung metastasis is the major cause of death in patients with triple-negative breast cancer (TNBC). Tumor-associated macrophages (TAMs) represent the M2-like phenotype with potent immunosuppressive activity, and play a pro-tumor role in TNBC lung metastasis. Sohlh2 belongs to the basic helix-loop-helix transcription factor family. However, its role in macrophages polarization remains unknown, especially in TNBC progression. Here we demonstrated that Sohlh2 overexpression promoted M2 macrophage polarization. Moreover, high expression of Sohlh2 in M2-like macrophage enhanced TNBC cell growth, migration and lung metastasis in vivo and in vitro. Mechanistically, we revealed that Sohlh2 functioned through up-regulating LXRα, ABCA1, ABCG1 expression and disturbing the lipid homeostasis on the membrane of macrophages. Sohlh2 could directly bind to the promoter of LXRα and promote its transcription activity. E3 ubiquitin ligase TRIM21 promoted Sohlh2 ubiquitination and degradation, and suppressed M2 macrophage polarization and TNBC progression. Collectively, our findings suggested that Sohlh2 in macrophage could be a novel therapeutic target for TNBC metastatic treatment.
- Open Access
- 24 October 2023
- Published by Springer Nature in Cell Death & Disease
- Vol. 14 (10) , 1-13
Sohlh2 promotes pulmonary fibrosis via repression of p62/Keap1/Nrf2 mediated anti-oxidative signaling pathway
Disturbance in the redox balance of alveolar epithelial cells (AECs) was considered as a causal factor for pulmonary fibrosis. The regulatory mechanisms of redox hemostasis in the development of pulmonary fibrosis remain largely unknown. Using a type II AEC-specific Sohlh2 conditional knock-in (CKI) mouse model, we found that Sohlh2, a basic HLH transcription factor, accelerated age-related pulmonary fibrosis. High-fat diet (HFD) resulted in a tremendous increase in lung inflammation and fibrotic changes in the lung tissues of Sohlh2 CKI mice. Sohlh2 overexpression led to a significant rise of intracellular ROS and apoptosis in the lung, mouse primary AECIIs, and human A549 cells, which was attenuated by ROS inhibitor (NAC). Sohlh2 enhanced oxidative stress via repressing p62/Keap1/Nrf2 mediated anti-oxidative signaling pathway. p62, a direct target of Sohlh2, mediated Sohlh2 effects on ROS generation and apoptosis in A549 cells. Hence, our findings elucidate a pivotal mechanism underlying oxidative stress-induced pulmonary fibrosis, providing a framework for aging-related disorder interventions.
- 24 October 2023
- Published by Springer Nature in Cell Death & Disease
- Vol. 14 (10) , 1-13
Open AccessSohlh2 promotes pulmonary fibrosis via repression of p62/Keap1/Nrf2 mediated anti-oxidative signaling pathway
Disturbance in the redox balance of alveolar epithelial cells (AECs) was considered as a causal factor for pulmonary fibrosis. The regulatory mechanisms of redox hemostasis in the development of pulmonary fibrosis remain largely unknown. Using a type II AEC-specific Sohlh2 conditional knock-in (CKI) mouse model, we found that Sohlh2, a basic HLH transcription factor, accelerated age-related pulmonary fibrosis. High-fat diet (HFD) resulted in a tremendous increase in lung inflammation and fibrotic changes in the lung tissues of Sohlh2 CKI mice. Sohlh2 overexpression led to a significant rise of intracellular ROS and apoptosis in the lung, mouse primary AECIIs, and human A549 cells, which was attenuated by ROS inhibitor (NAC). Sohlh2 enhanced oxidative stress via repressing p62/Keap1/Nrf2 mediated anti-oxidative signaling pathway. p62, a direct target of Sohlh2, mediated Sohlh2 effects on ROS generation and apoptosis in A549 cells. Hence, our findings elucidate a pivotal mechanism underlying oxidative stress-induced pulmonary fibrosis, providing a framework for aging-related disorder interventions.
- 20 July 2023
- Published by Elsevier in Médecine Nucléaire
- Vol. 48 (1) , 8-15
Performance of 18F-FDG PET/MR on TNM staging of pancreatic cancer compared with 18F-FDG PET/CT: A retrospective cohort study
- 20 July 2023
- Published by Elsevier in Médecine Nucléaire
- Vol. 48 (1) , 8-15
Performance of 18F-FDG PET/MR on TNM staging of pancreatic cancer compared with 18F-FDG PET/CT: A retrospective cohort study